AEM (psychedelic): Difference between revisions
Jump to navigation
Jump to search
m Protected "AEM (psychedelic)": Protecting pages from unwanted edits ([edit=sysop] (indefinite) [move=sysop] (indefinite)) |
m Robot: Automated text replacement (-{{WikiDoc Cardiology Network Infobox}} +, -<references /> +{{reflist|2}}, -{{reflist}} +{{reflist|2}}) |
||
| Line 21: | Line 21: | ||
==References== | ==References== | ||
{{reflist}} | {{reflist|2}} | ||
== See also == | == See also == | ||
Latest revision as of 13:54, 4 September 2012
| Alpha-Ethyl-Mescaline | |
|---|---|
| Chemical name | 3,4,5-trimethoxy-alpha-ethylphenethylamine or 3,4,5-trimethoxy-1-ethyl-(alpha-ethyl)amine |
| Chemical formula | C13H21NO3 |
| Molecular mass | 239.31 g/mol |
| SMILES | COc1c(cc(cc1OC)CC(N)CC)OC |
| File:AE-mescaline.png File:AEM-3d-sticks.png | |
AEM, Alpha-ethyl-mescaline or 3,4,5-trimethoxy-alpha-ethylphenethylamine, is a lesser-known psychedelic drug. It is an analog of Mescaline. AEM was first synthesized by Alexander Shulgin. In his book PIHKAL (Phenethylamines I Have Known and Loved), the minimum dosage is listed as 220 mg, and the duration unknown.[1] AEM produces few to no effects. Very little data exists about the pharmacological properties, metabolism, and toxicity of AEM.